Home ›
Trademark Categories ›
Pharmaceuticals ›
2008 ›
ES ›
ESTROPA
Trademark search for:
ESTROPA
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2015-03-27 — Application filed
2015-03-31 — Application filed
2015-04-06 — Application filed
2015-06-17 — Assigned to examiner
2015-06-19 — Final disposition recorded
2015-06-19 — Final disposition recorded
2015-06-19 — Final disposition recorded
2015-06-23 — Teas change of correspondence received
2015-12-10 — Office action issued
2015-12-10 — Correspondence received in law office
2015-12-11 — Teas/email correspondence entered
2015-12-12 — Removed from teas plus
2015-12-12 — Final disposition recorded
2015-12-12 — Final disposition recorded
2015-12-12 — Final disposition recorded
2016-05-04 — Office action issued
2016-05-17 — Assigned to lie
2016-05-20 — Correspondence received in law office
2016-05-20 — Teas/email correspondence entered
2016-05-21 — Approved for pub - principal register
2016-05-31 — Law office publication review completed
2016-06-15 — Notification of notice of publication e-mailed
2016-07-05 — Published for opposition
2016-07-05 — Official gazette publication confirmation e-mailed
2016-08-30 — Noa e-mailed - sou required from applicant
2017-02-14 — Teas revoke/app/change addr of atty/dom rep received
2017-02-14 — Attorney/dom.rep.revoked and/or appointed
2017-02-27 — Sou teas extension received
2017-02-27 — Sou extension 1 filed
2017-02-27 — Sou extension 1 granted
2017-03-01 — Notice of approval of extension request e-mailed
2017-10-02 — Application abandoned
2017-10-02 — Application abandoned
2017-10-02 — Final status recorded
Owner Information
Glaxo Group Limited
Glaxo Group Limited
Correspondent
Angela L. Wilson GSK
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
